Differences in biopsy features between prostate cancers located in the transition and peripheral zone

BJU International

Volumn 91, Issue 6, 2003, Pages 477-481

  Augustin, H ^a,b   Erbersdobler, A ^a   Graefen, M ^a   Jaekel, T ^a   Haese, A ^a   Huland, H ^a   Hammerer, P G ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c KLINIKUM BRAUNSCHWEIG   (Germany)

Author keywords

Prostate biopsy; Prostatectomy; Prostatic neoplasms; Zonal anatomy

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER LOCALIZATION; CANCER SURGERY; CHI SQUARE TEST; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PATHOLOGICAL ANATOMY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; STUDENT T TEST; TUMOR BIOPSY;

ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0038029366     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04140.x     Document Type: Article

References (24)

1. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma: correlation with histologic pattern and direction of spread. Am J Surg Path 1988; 12: 897-906
2. Reissigl A, Pointner J, Strasser H, Ennemoser O, Klocker H, Bartsch G. Frequency and clinical significance of transition zone cancer in prostate cancer screening. Prostate 1997; 30: 130-5
3. Greene DR, Wheeler TM, Egawa S, Dunn JK, Scardino PT. A comparison of the morphological features of cancers arising in the transition zone and in the peripheral zone of the prostate. J Urol 1991; 146: 1069-76
4. Stamey TA, Sozen TS, Yemoto CM, McNeal JE. Classification of localized untreated prostate cancer based on 791 men treated only with radical prostatectomy: common ground for therapeutic trials and TNM subgroups. J Urol 1998; 159: 2009-12
5. Noguchi M, Stamey TA, Neal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 2000; 163: 1751-5
6. Stamey TA, Yemoto CM, McNeal JE, Sigal BM, Johnstone IM. Prostate cancer is highly predictable, a prognostic equation based on all morphological variables in radical prostatectomy specimens. J Urol 2000; 163: 1155-60
7. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58: 843-8
8. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90: 766-71
9. King CR. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer 2000; 90: 305-11
10. Cookson MS, Fleshner NE, Soloway SM, Fair WR. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 1997; 157: 559-62
11. Bostwick DG. Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies. Am J Surg Path 1994; 18: 796-803
12. Spires SE, Cibull ML, Wood DP Jr, Miller S, Spires SM, Banks ER. Gleason histologic grading in prostate carcinoma. Correlation of 18-gauge core biopsy with prostatectomy. Arch Path Laboratory Med 1994; 118: 705-8
13. Henke RP, Krueger E, Ayhan N, Huebner D, Hammerer H, Huland H. Immunohistochemical detection of p53 protein in human prostatic cancer. J Urol 1994; 152: 1297-301
14. Sobin LH, Wittekind C. UICC TNM Classification of Malignant Tumors, 5th edn. New York: Wiley-Liss, 1997: 170-3
15. Gleason DJ, Mellinger GT. Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111: 58-64
16. Grignon DJ, Sakr WA. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J Cell Biochem 1994; 19 (Suppl): 267-76
17. Erbersdobler A, Hammerer P, Huland H, Henke RP. Numerical chromosomal aberrations in transition zone carcinomas of the prostate. J Urol 1997; 158: 1594-8
18. Erbersdobler A, Fritz H, Schnoeger S et al. Tumour grade, proliferation, apoptosis, microvessel density, p53 and bcl-2 in prostate cancers: differences between tumours located in the transition zone and the peripheral zone. Eur Urol 2002; 41: 40-6
19. Stamey TA, Dietrick DD, Issa MM. Large, organ confined, impalpable transition zone prostate cancer: association with metastatic levels of prostate specific antigen. J Urol 1993; 149: 510-5
20. Stamey TA. Making the most out of six systematic sextant biopsies. Urology 1995; 45: 2-12
21. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma loci: biopsy strategy implications. Cancer 2000; 89: 1800-9
22. Thickman D, Speers WC, Philpott PJ, Shapiro H. Effect of number of core biopsies of the prostate on predicting Gleason score of prostate cancer. J Urol 1996; 156: 110-3
23. Noguchi M, Stamey TA, McNeal JE, Yemoto CM. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable cancer. J Urol 2001; 166: 104-9
24. Liu IJ, Macy M, Lai YH, Terris MK. Critical evaluation of the current indications for transition zone biopsies. Urology 2001; 57: 1117-20